BMP7, a putative regulator of epithelial homeostasis in the human prostate, is a potent inhibitor of prostate cancer bone metastasis in vivo: Buijs JT, Rentsch CA, van der Horst G, van Overveld PG, Wetterwald A, Schwaninger R, Henriquez NV, Ten Dijke P, Borovecki F, Markwalder R, Thalmann GN, Papapoulos SE, Pelger RC, Vukicevic S, Cecchini MG, Löwik CW, van der Pluijm G, Department of Urology, Leiden University Medical Center, Leiden, The Netherlands

Autor: Li, Yingming, Koeneman, Kenneth S.

Publikováno v: In Urologic Oncology: Seminars and Original Investigations 2009 27(1):112-113

Further validation of the association between MAPT haplotype-tagging polymorphisms and Alzheimer's disease: neuropsychological tests, cerebrospinal fluid biomarkers, and APOE genotype.

Autor: Babić Leko M; Department for Neuroscience, Croatian Institute for Brain Research, University of Zagreb Medical School, Zagreb, Croatia., Španić Popovački E; Department for Neuroscience, Croatian Institute for Brain Research, University of Zagreb Medical School, Zagreb, Croatia., Willumsen N; Reta Lila Weston Institute, Department of Clinical and Movement Neuroscience, UCL Queen Square Institute of Neurology, London, United Kingdom., Nikolac Perković M; Division of Molecular Medicine, Ruđer Bošković Institute, Zagreb, Croatia., Pleić N; Department of Biology and Human Genetics, School of Medicine, University of Split, Split, Croatia., Zubčić K; Department of Molecular Diagnostics and Genetics, Dubrava University Hospital, Zagreb, Croatia., Langer Horvat L; Department for Neuroscience, Croatian Institute for Brain Research, University of Zagreb Medical School, Zagreb, Croatia., Vogrinc Ž; Laboratory for Neurobiochemistry, Department of Laboratory Diagnostics, University Hospital Centre Zagreb, Zagreb, Croatia., Boban M; Department of Neurology, University Hospital Centre Zagreb, Kišpatićeva, Zagreb, Croatia.; School of Medicine, University of Zagreb, Zagreb, Croatia., Borovečki F; Department of Neurology, University Hospital Centre Zagreb, Kišpatićeva, Zagreb, Croatia.; School of Medicine, University of Zagreb, Zagreb, Croatia.; Department for Functional Genomics, Centre for Translational and Clinical Research, University of Zagreb Medical School, Zagreb, Croatia., Zemunik T; Department of Biology and Human Genetics, School of Medicine, University of Split, Split, Croatia.; Department of Nuclear Medicine, University Hospital Split, Split, Croatia., de Silva R; Reta Lila Weston Institute, Department of Clinical and Movement Neuroscience, UCL Queen Square Institute of Neurology, London, United Kingdom., Šimić G; Department for Neuroscience, Croatian Institute for Brain Research, University of Zagreb Medical School, Zagreb, Croatia.

Publikováno v: Frontiers in molecular neuroscience [Front Mol Neurosci] 2024 Sep 25; Vol. 17, pp. 1456670. Date of Electronic Publication: 2024 Sep 25 (Print Publication: 2024).

Quality assurance for next-generation sequencing diagnostics of rare neurological diseases in the European Reference Network.

Autor: Maver A; Clinical Institute of Genomic Medicine, University Medical Centre Ljubljana, Ljubljana, Slovenia., Lohmann K; Institute of Neurogenetics, University of Luebeck, Luebeck, Germany., Borovečki F; Department of Neurology, University Hospital Centre Zagreb, Zagreb, Croatia., Wolstenholme N; EMQN CIC, Unit 4 Enterprise Hse, Manchester Science Park, Manchester, UK., Taylor RL; EMQN CIC, Unit 4 Enterprise Hse, Manchester Science Park, Manchester, UK., Spielmann M; Institute of Human Genetics, University of Lübeck, Lübeck, Germany., Haack TB; Institute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany., Gerberding M; Institute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany., Peterlin B; Clinical Institute of Genomic Medicine, University Medical Centre Ljubljana, Ljubljana, Slovenia., Graessner H; Institute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany. Holm.Graessner@med.uni-tuebingen.de.; Centre for Rare Diseases, University of Tübingen, Tübingen, Germany. Holm.Graessner@med.uni-tuebingen.de.

Publikováno v: European journal of human genetics : EJHG [Eur J Hum Genet] 2024 Aug; Vol. 32 (8), pp. 1014-1021. Date of Electronic Publication: 2024 Jun 05.

An EP2 Receptor-Selective Prostaglandin E 2 Agonist Induces Bone Healing

Autor: Paralkar, V. M., Borovecki, F., Ke, H. Z., Cameron, K. O., Lefker, B., Grasser, W. A., Owen, T. A., Li, M., DaSilva-Jardine, P., Zhou, M., Dunn, R. L., Dumont, F., Korsmeyer, R., Krasney, P., Brown, T. A., Plowchalk, D., Vukicevic, S., Thompson, D. D.

Publikováno v: Proceedings of the National Academy of Sciences of the United States of America, 2003 May . 100(11), 6736-6740.

Externí odkaz: https://www.jstor.org/stable/3144134

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.